Guardant Health, Inc.·4

May 22, 4:58 PM ET

Saia John G. 4

4 · Guardant Health, Inc. · Filed May 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Guardant Health (GH) CLO John Saia Sells 20,000 Shares

What Happened
John G. Saia, Chief Legal Officer of Guardant Health (GH), sold a total of 20,000 shares on May 20, 2026 in three open-market transactions. The sales were: 5,632 shares at a weighted average price of $105.34 (proceeds $593,293), 7,187 shares at $106.71 (proceeds $766,939), and 7,181 shares at $107.23 (proceeds $769,996), for total proceeds of approximately $2,130,228. These were sales (dispositions), not purchases or option exercises.

Key Details

  • Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (timely filing).
  • Reported sales (S) in three groups: 5,632 @ $105.34; 7,187 @ $106.71; 7,181 @ $107.23.
  • Total shares sold: 20,000; total reported proceeds: ~$2.13M.
  • Footnotes: Each line reflects a weighted average price; underlying trades occurred across price ranges: $105.00–$105.86, $106.00–$106.99, and $107.00–$107.96. The reporting person has offered to provide exact per-price breakdowns to the SEC or shareholders on request.
  • Shares owned after transaction: not specified in the provided filing excerpt.

Context
These were open-market sales, which are commonly routine (e.g., diversification or liquidity) and do not by themselves indicate company performance or management outlook. No options exercise, award, or gift was reported in this filing. The filing was submitted within the normal Form 4 timeframe (two business days), so the report appears timely.

Insider Transaction Report

Form 4
Period: 2026-05-20
Saia John G.
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    [F1]
    2026-05-20$105.34/sh5,632$593,29360,318 total
  • Sale

    Common Stock

    [F2]
    2026-05-20$106.71/sh7,187$766,93953,131 total
  • Sale

    Common Stock

    [F3]
    2026-05-20$107.23/sh7,181$769,99645,950 total
Footnotes (3)
  • [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.86. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.96. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Signature
/s/ John G. Saia|2026-05-22

Documents

1 file
  • 4
    wk-form4_1779483506.xmlPrimary

    FORM 4